Medicine and Dentistry
Breast Cancer
86%
Neoplasm
80%
Biological Marker
55%
Physical Activity
49%
Colorectal Adenoma
48%
Body Mass Index
38%
Postmenopause
35%
Adenoma
34%
Disease
28%
Odds Ratio
27%
Malignant Neoplasm
27%
Logistic Regression Analysis
25%
Randomized Controlled Trial
25%
Breast Density
24%
Cardiometabolic Risk
24%
Cancer Prevention
24%
Bone Strength
22%
Obesity
21%
Diabetes Prevention
21%
Defibrillation
21%
Wart Virus
21%
Prevalence
21%
Magnetic Resonance Imaging
21%
In Vitro
20%
Maturity Onset Diabetes of the Young
19%
Reproducibility
19%
Aromatase Inhibitor
18%
Pediatrics
18%
Cervical Cancer
18%
Recurrent Disease
18%
Bone Density
18%
Metabolic Syndrome
18%
Ursodeoxycholic Acid
18%
Cancer Diagnosis
17%
Papillomavirus Infection
17%
Endometrial Cancer
17%
Heart Arrest
17%
Colorectal Cancer
16%
Pancreas Adenocarcinoma
16%
Tai Chi
16%
Arthralgia
16%
Uterine Cancer
16%
Drug Therapy
16%
Dual-Energy X-Ray Absorptiometry
15%
Lavage
14%
Health Care Cost
13%
Sodium Bicarbonate
13%
Estrogen Receptor
13%
Carcinogenesis
13%
Cost-Effectiveness Analysis
13%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Placebo
60%
Breast Cancer
54%
Colorectal Adenoma
53%
Malignant Neoplasm
46%
Recurrent Disease
39%
Clinical Trial
33%
Bile Acid
33%
Adenoma
31%
Biological Marker
31%
Human Papillomavirus
29%
Disease
27%
Randomized Controlled Trial
25%
Vitamin D
25%
Metoclopramide
24%
Ursodeoxycholic Acid
21%
Prostaglandin E2
21%
Celecoxib
20%
Actinic Keratosis
18%
Non Melanoma Skin Cancer
18%
Mouse
18%
Phase II Trials
18%
Paclitaxel
17%
Selenomethionine
17%
Ovary Cancer
17%
Cancer Incidence
16%
Squamous Cell Carcinoma
16%
Antiemetic Agent
16%
Colon Polyp
16%
Cyclophosphamide
16%
Prevalence
16%
Non Insulin Dependent Diabetes Mellitus
16%
Oxylipin
16%
Bendamustine
16%
Aromatase Inhibitor
16%
Colorectal Cancer
15%
Basal Cell Carcinoma
13%
Skin Cancer
13%
Dicarbonate
13%
Estrogen Receptor
13%
Polyamine
13%
Doxorubicin
13%
Chemotherapy
13%
Papillomavirus Infection
12%
Colon Cancer
12%
Anticarcinogen
12%
Non-Steroidal Anti-Inflammatory Drug
11%
P-Glycoprotein
11%
Hyperthermia
11%
Adverse Event
11%
Keyphrases
Wheat Bran Fiber
46%
Confidence Interval
42%
Colorectal Adenoma
37%
Vitamin D Metabolites
32%
Odds Ratio
31%
Physical Activity
26%
Randomized Controlled Trial
25%
Prostaglandin E2
25%
Adenoma Recurrence
24%
Fecal Bile Acids
24%
Metoclopramide
24%
Crossover Comparison
24%
1,25(OH)2D3
23%
Colorectal Adenoma Recurrence
21%
25-hydroxyvitamin D (25OHD)
21%
Ursodeoxycholic Acid
18%
Phase II Study
18%
Dose-response
17%
Papillomavirus Infections
17%
Postmenopausal Women
16%
Randomized Crossover
16%
Antiemetics
16%
Celecoxib
16%
Metastatic Melanoma
16%
High Dose
16%
Adiposity
16%
Breast Density
16%
Cardiometabolic Risk
16%
Rectal mucosa
16%
Colon Polyps
16%
Aromatase Inhibitor-induced Arthralgia
16%
Tai Chi Easy
16%
Cancer Prevention Guidelines
16%
Non-melanoma Skin Cancer
16%
Oxylipins
16%
Acid Concentration
16%
Oncogenic Human Papillomavirus
16%
Aromatase Inhibitors
16%
Sulindac
16%
Endometrial Cancer
16%
Infertility
16%
Fiber Intake
15%
Body Mass Index
14%
Adenoma
14%
Risk Factors
14%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
13%
Prevention Trials
13%
Cervicovaginal Lavage
13%
Cancer Patients
13%
Bone Strength
12%
